insights_auto
Why is AQB up 13.21%?
Dive Deeperchevron_right
AQB:NASDAQ
Aquabounty Technologies Inc
$0.93
arrow_upward
+13.21%(+0.11) 1D
$0.92
arrow_downward
-1.69% (-0.016)bedtimeAfter hours
Closed: Nov 18, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AQB...
Open
$0.79
High
$0.97
Low
$0.76
Mkt. cap
12.35M
Avg. vol.
167.45K
Volume
0.00
52-wk high
$1.64
52-wk low
$0.71
EPS
-$4.51
Beta
1.45
Shares outstanding
13.29M
No. of employees
3
Open
$0.79
High
$0.97
Low
$0.76
Mkt. cap
12.35M
Avg. vol.
167.45K
Volume
0.00
52-wk high
$1.64
52-wk low
$0.71
EPS
-$4.51
Beta
1.45
Shares outstanding
13.29M
No. of employees
3
News stories
From web sources and news partners
BigGo Finance
·
4 hours ago
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
3 hours ago
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
TradingView
·
3 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
Traders Union
·
6 hours ago
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024. Wikipedia
About Aquabounty Technologies Inc
CEO-
Employees3
Founded1991
HeadquartersHarvard, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteaquabounty.com